Samsara BioCapital »

Bolt Biotherapeutics shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2025-09-30 $260k 49k 5.32
2025-06-30 $303k 53k 5.77

More positions owned by Samsara BioCapital

Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Kalaris Therapeutics (KLRS)
Septerna (SEPN)
Neurogene (NGNE)
Alumis (ALMS)
Upstream Bio (UPB)
Gossamer Bio (GOSS)
Lenz Therapeutics (LENZ)
Aquestive Therapeutics (AQST)
Palvella Therapeutics Inc Ne (PVLA)
Avadel Pharmaceuticals Com Shs (AVDL)
Vtv Therapeutics Cl A New (VTVT)
Nkarta (NKTX)
Contineum Therapeutics Cl A (CTNM)

View all positions for Samsara BioCapital

Top funds holding Bolt Biotherapeutics

Vivo Capital
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Tang Capital Management
Nan Fung Group Holdings
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Vanguard Group
Pfizer
Renaissance Technologies
Geode Capital Management
Susquehanna International
Shay Capital
Squarepoint Ops
DRW Holdings

View all funds holding Bolt Biotherapeutics